Cargando…

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines

Patients with HPV-positive head and neck squamous cell carcinoma (HNSCC) show better survival rates than those with HPV-negative HNSCC. While an enhanced radiosensitivity of HPV-positive tumors is clearly evident from single modality treatment, cisplatin is never administered as monotherapy and ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busch, Chia-Jung, Becker, Benjamin, Kriegs, Malte, Gatzemeier, Fruzsina, Krüger, Katharina, Möckelmann, Nikolaus, Fritz, Gerhard, Petersen, Cordula, Knecht, Rainald, Rothkamm, Kai, Rieckmann, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094966/ https://www.ncbi.nlm.nih.gov/pubmed/27127883 http://dx.doi.org/10.18632/oncotarget.9028

Ejemplares similares

Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells
por: Hintelmann, Katharina, et al.
Publicado: (2021)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
por: Oetting, Agnes, et al.
Publicado: (2023)

A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells
por: Köcher, Sabrina, et al.
Publicado: (2022)

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests
por: Kriegs, Malte, et al.
Publicado: (2016)

Analyzing expression and phosphorylation of the EGF receptor in HNSCC
por: Kriegs, Malte, et al.
Publicado: (2019)

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells
por: Cetin, Meryem H., et al.
Publicado: (2023)

The inflammation-reducing compatible solute ectoine does not impair the cytotoxic effect of ionizing radiation on head and neck cancer cells
por: Rieckmann, Thorsten, et al.
Publicado: (2019)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
por: Wurlitzer, Marcus, et al.
Publicado: (2020)

The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective
por: Rieckmann, Thorsten, et al.
Publicado: (2019)

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting
por: Hintelmann, Katharina, et al.
Publicado: (2020)

Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer
por: Busch, Chia-Jung, et al.
Publicado: (2022)

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
por: Struve, Nina, et al.
Publicado: (2015)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities
por: Struve, Nina, et al.
Publicado: (2021)

Analyzing the influence of kinase inhibitors on DNA repair by differential proteomics of chromatin-interacting proteins and nuclear phospho-proteins
por: Gleißner, Lisa, et al.
Publicado: (2017)

Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines
por: Riedel, Matthias, et al.
Publicado: (2016)

The Impact of YRNAs on HNSCC and HPV Infection
por: Guglas, Kacper, et al.
Publicado: (2023)

CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
por: Trembley, Janeen H., et al.
Publicado: (2021)

DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients
por: Bold, Ioan T., et al.
Publicado: (2021)

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
por: Braig, Friederike, et al.
Publicado: (2016)

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
por: Borgmann, Mara, et al.
Publicado: (2022)

Hepatitis B Virus Reactivation Following Treatment of HNSCC With Cisplatin
por: Crosby, James, et al.
Publicado: (2022)

Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells
por: Grottker, Fridolin, et al.
Publicado: (2023)

Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
por: Weiss, Daniel, et al.
Publicado: (2012)

Interplay between Partial EMT and Cisplatin Resistance as the Drivers for Recurrence in HNSCC
por: Ingruber, Julia, et al.
Publicado: (2022)

HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients
por: Rivera-Peña, Bianca, et al.
Publicado: (2016)

mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC
por: Coppock, Joseph D., et al.
Publicado: (2016)

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort
por: Qin, Tingting, et al.
Publicado: (2018)

HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients
por: Burr, Adam R, et al.
Publicado: (2018)

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020)

GA-OH enhances the cytotoxicity of photon and proton radiation in HPV(+) HNSCC cells
por: Chitsike, Lennox, et al.
Publicado: (2023)

FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients
por: Wang, Yating, et al.
Publicado: (2017)

Enhancer RNA Profiling in Smoking and HPV Associated HNSCC Reveals Associations to Key Oncogenes
por: Shende, Neil, et al.
Publicado: (2021)

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
por: Harris, Matthew, et al.
Publicado: (2011)

EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma
por: Struve, Nina, et al.
Publicado: (2020)

HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC
por: Zeng, Hao, et al.
Publicado: (2020)

HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway
por: Huang, Zixian, et al.
Publicado: (2022)

Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
por: Bteich, Yara T, et al.
Publicado: (2022)

Tirapazamine-cisplatin: the synergy.
por: Gatzemeier, U., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_43n657c9d8tbufbmsts3140fbp